CompletedPHASE2, PHASE3NCT01529060
Phenylbutyrate Therapy for Maple Syrup Urine Disease
Studying Maple syrup urine disease
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Brendan Lee
- Principal Investigator
- Brendan Lee, M.D., Ph.D.Baylor College of Medicine
- Intervention
- Phenylbutyrate(drug)
- Enrollment
- 20 enrolled
- Eligibility
- 3 years · All sexes
- Timeline
- 2013 – 2017
Study locations (1)
- Baylor College of Medicine, Houston, Texas, United States
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT01529060 on ClinicalTrials.gov